Kunpeng Du

540 total citations
37 papers, 356 citations indexed

About

Kunpeng Du is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Kunpeng Du has authored 37 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Kunpeng Du's work include Epigenetics and DNA Methylation (6 papers), Ferroptosis and cancer prognosis (5 papers) and RNA modifications and cancer (5 papers). Kunpeng Du is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Ferroptosis and cancer prognosis (5 papers) and RNA modifications and cancer (5 papers). Kunpeng Du collaborates with scholars based in China, Cambodia and United States. Kunpeng Du's co-authors include Baiyao Wang, Yawei Yuan, Chengcong Chen, Chunshan Liu, Jie Lin, Mei-Ling Ai, Muhammad Khan, Bohong Cen, Tao Xie and Xiaoting Huang and has published in prestigious journals such as Advanced Functional Materials, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Kunpeng Du

28 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kunpeng Du China 13 182 125 101 78 69 37 356
Ruotian Wang China 10 118 0.6× 75 0.6× 81 0.8× 82 1.1× 34 0.5× 38 310
Fei Ju China 12 119 0.7× 73 0.6× 76 0.8× 72 0.9× 29 0.4× 19 351
Xiaonan Shen China 9 156 0.9× 110 0.9× 69 0.7× 65 0.8× 50 0.7× 19 320
Jinhua Song China 9 180 1.0× 106 0.8× 128 1.3× 61 0.8× 76 1.1× 35 390
Monica Mead United States 9 154 0.8× 165 1.3× 55 0.5× 37 0.5× 55 0.8× 34 427
Xiaoliang Wu China 8 174 1.0× 102 0.8× 137 1.4× 34 0.4× 117 1.7× 13 371
Pei‐Chi Hou Taiwan 10 226 1.2× 90 0.7× 121 1.2× 63 0.8× 73 1.1× 16 409
Travis Laver United States 10 171 0.9× 90 0.7× 122 1.2× 104 1.3× 91 1.3× 17 384
Huihui Yao China 8 130 0.7× 97 0.8× 94 0.9× 67 0.9× 61 0.9× 22 268
Zifeng Xu China 11 147 0.8× 125 1.0× 89 0.9× 57 0.7× 41 0.6× 28 334

Countries citing papers authored by Kunpeng Du

Since Specialization
Citations

This map shows the geographic impact of Kunpeng Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kunpeng Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kunpeng Du more than expected).

Fields of papers citing papers by Kunpeng Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kunpeng Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kunpeng Du. The network helps show where Kunpeng Du may publish in the future.

Co-authorship network of co-authors of Kunpeng Du

This figure shows the co-authorship network connecting the top 25 collaborators of Kunpeng Du. A scholar is included among the top collaborators of Kunpeng Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kunpeng Du. Kunpeng Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhou, Ying, Kunpeng Du, Yiqing Zhang, et al.. (2025). Spin‐Coating Free Fabrication of α‐FAPbI 3 ‐Based Efficient Inverted Perovskite Solar Cells via Mixed Self‐Assembled Molecules. Advanced Functional Materials. 36(25).
3.
Li, Lilin, Yaru Zhu, Kunpeng Du, et al.. (2025). Unveiling the multifaceted role of the FLNC gene: implications for cancer diagnosis and prognosis. European journal of medical research. 30(1). 608–608. 1 indexed citations
4.
Liu, Xiang, Yi Liu, Kunpeng Du, et al.. (2025). EPB41L3 as a prognostic biomarker suppressing cellular malignancy and correlating with the immune microenvironment in glioma. Biochemical and Biophysical Research Communications. 778. 152305–152305.
5.
Que, Qingmin, Chunmei Li, Wei Zhou, et al.. (2024). In vitro shoot regeneration system from leaves wrapped by bud scales of a multipurpose tree (Neolamarckia cadamba). Plant Cell Tissue and Organ Culture (PCTOC). 158(2).
6.
Du, Kunpeng, et al.. (2024). A novel assembly-oriented measurement datum transformation and tolerance reallocation method. The International Journal of Advanced Manufacturing Technology. 131(7-8). 4281–4295.
7.
Wang, Changqian, Xiang Liu, Lilin Li, et al.. (2024). A signature based on circadian rhythm-associated genes for the evaluation of prognosis and the tumour microenvironment in HNSCC. Scientific Reports. 14(1). 7594–7594.
8.
Li, Lilin, Xiang Liu, Changqian Wang, et al.. (2024). The causal relationship between immune cells and hepatocellular carcinoma: a Mendelian randomization (MR). ecancermedicalscience. 18. 1794–1794.
9.
10.
Li, Lilin, Kunpeng Du, Xiang Liu, et al.. (2022). Integrative Pan-Cancer Analysis Confirmed that FCGR3A is a Candidate Biomarker Associated With Tumor Immunity. Frontiers in Pharmacology. 13. 900699–900699. 15 indexed citations
11.
Xie, Tao, Kunpeng Du, Wei Liu, et al.. (2022). LHX2 facilitates the progression of nasopharyngeal carcinoma via activation of the FGF1/FGFR axis. British Journal of Cancer. 127(7). 1239–1253. 6 indexed citations
12.
Du, Kunpeng, Jingwen Zou, Baiyao Wang, et al.. (2022). A Metabolism-Related Gene Prognostic Index Bridging Metabolic Signatures and Antitumor Immune Cycling in Head and Neck Squamous Cell Carcinoma. Frontiers in Immunology. 13. 857934–857934. 14 indexed citations
13.
Wang, Qi, et al.. (2022). Distribution and conservation status of Chinese pangolin (<i>Manis pentadactyla</i>) in Jianfengling, Hainan. Biodiversity Science. 30(6). 22106–22106. 1 indexed citations
14.
Du, Kunpeng, Yanyang Li, Min Gong, et al.. (2022). A Meta-analysis of Total Neoadjuvant Therapies Combining Chemoradiotherapy with Induction or Consolidated Chemotherapy for Locally Advanced Rectal Cancer. Journal of Gastrointestinal Cancer. 54(3). 693–702. 2 indexed citations
15.
Tian, Yunhong, Chunshan Liu, Zhiyong Li, et al.. (2022). Exosomal B7–H4 from irradiated glioblastoma cells contributes to increase FoxP3 expression of differentiating Th1 cells and promotes tumor growth. Redox Biology. 56. 102454–102454. 29 indexed citations
16.
Khan, Muhammad, Mei-Ling Ai, Kunpeng Du, et al.. (2022). Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective. Frontiers in Immunology. 13. 1062225–1062225. 38 indexed citations
17.
Zhang, Jiän, Kunpeng Du, Tao Xie, et al.. (2021). Pan-Cancer Analysis of Genomic and Prognostic Characteristics Associated With Coronavirus Disease 2019 Regulators. Frontiers in Medicine. 8. 662460–662460. 7 indexed citations
18.
Huang, Xiaoting, Leyang Xiang, Baiyao Wang, et al.. (2021). CMTM6 promotes migration, invasion, and EMT by interacting with and stabilizing vimentin in hepatocellular carcinoma cells. Journal of Translational Medicine. 19(1). 120–120. 29 indexed citations
19.
Yu, Zhongjian, Xiongjie Zhu, Ying Li, et al.. (2021). Circ-HMGA2 (hsa_circ_0027446) promotes the metastasis and epithelial-mesenchymal transition of lung adenocarcinoma cells through the miR-1236-3p/ZEB1 axis. Cell Death and Disease. 12(4). 313–313. 31 indexed citations
20.
Wang, Qi, Zhile Liu, Kunpeng Du, et al.. (2019). Babaodan inhibits cell growth by inducing autophagy through the PI3K/AKT/mTOR pathway and enhances antitumor effects of cisplatin in NSCLC cells.. PubMed Central. 11(8). 5272–5283. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruotian Wang Breakdown of academic impact, for papers by Fei Ju Breakdown of academic impact, for papers by Xiaonan Shen Breakdown of academic impact, for papers by Jinhua Song Breakdown of academic impact, for papers by Monica Mead Breakdown of academic impact, for papers by Xiaoliang Wu Breakdown of academic impact, for papers by Pei‐Chi Hou Breakdown of academic impact, for papers by Travis Laver Breakdown of academic impact, for papers by Huihui Yao Breakdown of academic impact, for papers by Zifeng Xu
Rankless by CCL
2026